Doctors in Canada have made a fascinating new discovery while researching COVID 19 & Willie Nelson is gonna love it..
Researchers at the University of Lethbridge (ULeth), located in Alberta, Canada, recently published in peer journal Preprints, the results from a non peer-reviewed, preclinical study titled “In Search of Preventative Strategies: Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues.” Study results indicated hemp extracts high in CBD may help block proteins that provide a “gateway” for COVID-19 to enter host cells.
“Angiotensin-converting enzyme 2 (ACE2) has been generally accepted by the scientific community as a receptor required for the entry of SARS-CoV-2 into human cells,” said study author Dr. Igor Kovalchuk in a press release.
“Our initial findings warrant further investigation but it’s possible that medical cannabis products could become a safe adjunct therapy for the treatment of COVID-19,” Dr. Kovalchuk added.
The study was conducted in partnership with medical cannabis research and development company Pathway Rx, and cannabinoid-based oral health company Swysh, Inc.
Dr. Igor Kovalchuk is chief executive officer at Pathway Rx and holder of a Health Canada License for cannabis research. He and Dr. Olga Kovalchuk are both ULeth biology professors and study authors.